Sleep and Circadian Interventions for College Students at High Risk of Suicide
This study is looking at how different sleep and daily rhythm (circadian) treatments might help reduce the risk of suicide in college students. Researchers are testing three approaches: "Sleep Feedback + Psychoeducation" (using a watch to track sleep and providing information), "Transdiagnostic Sleep and Circadian Intervention + Bright Light" (TSC+, involving therapy sessions and daily bright light), and "Triple Chronotherapy" (TCT+, which includes one night of total sleep deprivation followed by three nights of sleep phase advancement, plus daily bright light). The goal is to see if these interventions, when added to standard psychiatric care, can quickly and effectively lower suicidal thoughts and behaviors. You might be able to join if you are 18-25 years old, fluent in English, have had suicidal thoughts or attempts recently, and experience significant sleep problems. The study aims to enroll 90 participants, but its current status is unclear.
- Study design
- This is an interventional study, meaning participants will receive specific treatments. It plans to enroll 90 participants, who will be randomly assigned to one of three intervention groups.
- What's involved
- Participants will wear an actigraphy watch and complete a daily sleep diary, or attend 6-8 therapy sessions (in-person or video) with daily bright light therapy, or undergo one night of total sleep deprivation followed by three nights of sleep phase advancement in a sleep lab, plus daily bright light therapy.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your suicidal thoughts and behaviors will be measured at the start of the intervention, and then again at 2 months and 6 months after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Sleep and Circadian Interventions for College Students at High Risk of Suicide
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Tina Goldstein, PhD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
- Peter Franzen · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Suicidal Thoughts and Behaviors via CSSRS(short term) Intervention Days 1-4
Columbia Suicide Severity Rating Scale, administered via clinician on Intervention Days 1-4. Range of 0-5, higher values represent higher severity/intensity
- Suicidal Thoughts and Behaviors via CSSRS(medium term) 2 month follow up
Columbia Suicide Severity Rating Scale, administered via clinician at 2 month follow up assessment. Range of 0-5, higher values represent higher severity/intensity
- Suicidal Thoughts and Behaviors via CSSRS(long term) 6 month follow up
Columbia Suicide Severity Rating Scale, administered via clinician at 6 month follow up assessment. Range of 0-5, higher values represent higher severity/intensity
- Suicidal Thoughts and Behaviors via LIFE SI/SIB scale(medium term) 2mo follow up
The Longitudinal Interval Follow-Up Evaluation (LIFE) Self Injurious/Suicidal Behaviors Measure, administered by clinician at the 2-month assessment (LIFE SI/SIB Range 0-5, higher number indicates greater lethality)
- Suicidal Thoughts and Behaviors via LIFE SI/SIB scale(long term) 6mo follow up
The Longitudinal Interval Follow-Up Evaluation (LIFE) Self Injurious/Suicidal Behaviors Measure, administered by clinician at the 6-month assessment (LIFE SI/SIB Range 0-5, higher number indicates greater lethality)
- Depression via KSADS Depression Rating Scale(short term) Intervention Days 1-4
The Kiddie Schedule for Affective Disorders and Schizophrenia-Depression Rating Scale, administered via clinician at Intervention Days 1-4. (KDRS Range 0-64 with higher scores indicating greater severity)
- Depression via KSADS Depression Rating Scale(medium term) 2mo follow up
The Kiddie Schedule for Affective Disorders and Schizophrenia-Depression Rating Scale, administered via clinician at 2 month follow up. (KDRS Range 0-64 with higher scores indicating greater severity)
- Depression via KSADS Depression Rating Scale(long term) 6mo follow up
The Kiddie Schedule for Affective Disorders and Schizophrenia-Depression Rating Scale, administered via clinician at 6 month follow up. (KDRS Range 0-64 with higher scores indicating greater severity)
- Depression via LIFE PSR(medium term) 2mo follow up
The Longitudinal Interval Follow-Up Evaluation (LIFE) Psychiatric Status Ratings, administered by clinician at the 2 month assessment (PSR; Range 1-6, higher numbers indicate greater severity)
- Depression via LIFE PSR(long term) 6mo follow up
The Longitudinal Interval Follow-Up Evaluation (LIFE) Psychiatric Status Ratings, administered by clinician at the 6 month assessment (PSR Range 1-6, higher numbers indicate greater severity)